Remecare SRL
3.8 FTEThe score of Remecare shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +7 % Headcount (avg FTE) -22 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Remecare's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Oct 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 30 Oct 2023
Remecare's financial analysis
- Solvency-132.1%sector median: 51.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Remecare
Remecare's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0774.519.660
- VAT number
- BE0774519660
- Peppol
- Registered · 0208:0774519660 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Sep 2021
- Registered office
- 2630 Aartselaar
- Size
- Micro · 3.8 FTE
- Latest accounts
- 2025 · filed on 09 Oct 2026
- Activity
- Manufacture of irradiation, electromedical and electrotherapeutic equipment (NACE 26600)
Remecare (SRL) has been based in Aartselaar since 2021, active in: manufacture of irradiation, electromedical and electrotherapeutic equipment. For 2025, it reports a net loss of €1.19m and equity of −€3.96m; its revenue is not published. With 3.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -132.1%, below the median of its sector (51.7%).
Companies similar to Remecare
Companies in the same business, of comparable size and area, outside its group.
- Myocene Manufacture of irradiation, electromedical and electrotherapeutic equipment Liège · balance sheet €3.51m
- MoveUP Manufacture of irradiation, electromedical and electrotherapeutic equipment Brussels · balance sheet €6.18m
- Mestag Manufacture of irradiation, electromedical and electrotherapeutic equipment Ganshoren · balance sheet 31,077 €
- Axinesis Manufacture of irradiation, electromedical and electrotherapeutic equipment Wavre · balance sheet €1.67m
- EL - RE Systems Manufacture of irradiation, electromedical and electrotherapeutic equipment Bilzen-Hoeselt · balance sheet 482,798 €
- Euromi Biosciences Manufacture of irradiation, electromedical and electrotherapeutic equipment Dison · balance sheet €4.58m
- Elmedix Manufacture of irradiation, electromedical and electrotherapeutic equipment Leuven · balance sheet €4.60m
- Eledricity Manufacture of irradiation, electromedical and electrotherapeutic equipment Merelbeke-Melle · balance sheet €5.09m
Frequently asked questions about Remecare
What is the revenue of Remecare?
Remecare files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Remecare?
In Belgium, the VAT number is the company number prefixed with BE: BE0774519660 for Remecare, if the company is VAT-registered. Its company number (CBE) is 0774.519.660.
Where is the registered office of Remecare?
According to the CBE register, the registered office of Remecare is in 2630 Aartselaar.
What is the equity of Remecare?
At the close of the 2025 financial year, the equity of Remecare amounts to -3,962,959 €, a solvency of -132.1% of total assets.
How many people work at Remecare?
3.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Remecare?
The register lists 4 active mandates at Remecare. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Remecare
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →